European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP

Sep 14, 2026

Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform, while HOPE Therapeutics advances robotic TMS deployment and the company's preservative-free ketamine program moves closer to commercialization

MIAMI - Sept. 14, 2026 - PRLog -- NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP is entering the week with another important development that expands the company's potential opportunity well beyond its original neuropsychiatric focus.

Today, September 14, GeNeuro, Inc., an NRx Pharmaceuticals subsidiary, announced that it has been awarded European Patent EP 3 570 878 B1 for GNK-301, a novel monoclonal antibody candidate targeting Human Endogenous Retrovirus K (HERV K) in Amyotrophic Lateral Sclerosis (ALS). The European patent builds on two previously issued U.S. patents and strengthens the intellectual-property position surrounding GeNeuro's ALS program.

For NRXP investors, today's announcement is important because it adds another potentially valuable clinical-development platform to a company already advancing preservative-free ketamine, NRX-101, advanced TMS and HOPE Therapeutics.

And it comes just days after another major announcement: HOPE Therapeutics is preparing to become the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared Zeta TMS Robotic System, with its Florida clinical team undergoing training ahead of deployment.

Taken together, the latest developments suggest NRx is becoming a considerably broader biotechnology platform.

Today's GeNeuro News Adds a Potential ALS Catalyst

GeNeuro's new European patent covers GNK-301, an antibody developed to target the HERV K envelope protein, or K Env.

According to today's announcement, K Env has been detected in the spinal fluid of more than 75% of people with ALS and has demonstrated neurotoxic effects in laboratory animals and human motor-neuron cell cultures. GNK-301 has been shown in nonclinical work to prevent those effects.

The patent is particularly notable because it adds European protection to two previously issued U.S. patents covering the underlying invention.

GeNeuro has also initiated cGMP manufacturing of GNK-301 and anticipates beginning first-in-human Phase 1 testing in ALS during the second half of 2027, subject to development and regulatory progress.

Why today's announcement matters to NRXP investors:
  • European patent protection expands the intellectual-property footprint for GNK-301.
  • The ALS program provides NRx with another potential high-value clinical opportunity.
  • GeNeuro's portfolio includes additional HERV-targeted programs.
  • GNK-301 has connections to research conducted with the U.S. National Institute of Neurological Disorders and Stroke.
  • GeNeuro has already been selected in the first round of the Congressionally Directed Medical Research Program for potential awards.

This is potentially important diversification for NRx.

HOPE Therapeutics Is Moving Robotic TMS Toward Real-World Deployment

Only three days before today's GeNeuro announcement, NRx reported another significant milestone.

On September 11, the company announced that HOPE Therapeutics will be the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared Zeta TMS Robotic System.

Clinical staff are completing orientation and training at Zeta Surgical's Boston headquarters ahead of deployment at HOPE's Florida clinics.

The robotic system builds upon the Zeta TMS Navigation System that HOPE began using earlier this summer.

Its AI-driven software is designed to adjust the TMS coil in real time, tracking patient movement and maintaining submillimeter precision.

This development is especially interesting because the technology directly supports NRx's SPARC-TMS program involving NRX-101 and robotic TMS.

In June, HOPE had already begun treating its first patients using Zeta's FDA-cleared TMS Navigation System in West Palm Beach and Sarasota, marking the transition from technology deployment to active patient care.

NRX-101 and DARPA Could Become Major Catalysts

NRX-101 remains one of NRx's most important pipeline programs.

The company is developing NRX-101, an oral fixed-dose combination of D-cycloserine and lurasidone, for serious neuropsychiatric conditions including suicidal bipolar depression.

NRx has received FDA Breakthrough Therapy Designation for NRX-101 and has advanced a program combining it with robotic-assisted TMS.

The potential scale of that opportunity increased substantially when NRx announced that its defense subsidiary was selected by DARPA as prime contractor for SPARC-TMS, an FDA-approved Phase 2/3 trial.

The anticipated non-dilutive funding is expected to exceed $11.5 million, subject to completion of contracting. The program could potentially expand the NRX-101 opportunity into the much larger treatment-resistant depression population.

The FDA Ketamine Story Remains Front and Center

Despite today's GeNeuro development, the most immediate potential commercial catalyst for NRx remains its preservative-free intravenous ketamine program.

On August 7, NRx announced that the FDA had completed its first-cycle review of the company's ANDA with no drug-related major deficiencies.

The remaining issue concerns certification involving the vial's luer-lock component. NRx has stated that no new clinical, safety or efficacy data are required for approval and that the requested manufacturer attestation has been submitted.

Meanwhile, the company is preparing for commercialization.

NRx has initiated commercial-scale manufacturing and is building approximately 5 million doses of launch inventory, with anticipated post-launch production capacity of approximately 1 million doses per month.

That means the company is attempting to have significant supply available if and when final regulatory clearance arrives.

$NRXP Has Strengthened Its Financial Position

The company also entered the second half of 2026 with a significantly stronger cash position.

NRx completed an institutionally supported public offering generating approximately $22.3 million in gross proceeds, including the underwriters' full exercise option.

As of June 30, NRx reported approximately $26.7 million in cash and equivalents, versus $7.8 million at year-end 2025. Management believes existing resources, anticipated clinic revenue and potential ATM utilization can support operations for at least one year.

This provides additional runway as the company simultaneously advances commercial manufacturing, clinical programs and HOPE Therapeutics.

A Much Broader NRx Platform Is Emerging

Over the past three-plus months, investors have watched NRx move through a remarkable sequence of developments:
  • FDA: First-cycle ANDA review completed with no drug-related major deficiencies.
  • Manufacturing: Commercial-scale production underway with a five-million-dose launch inventory target.
  • HOPE: First patients treated using Zeta's advanced TMS navigation technology.
  • Robotic TMS: HOPE preparing to deploy Zeta's newly FDA-cleared robotic TMS system.
  • NRX-101: FDA Breakthrough Therapy program advancing with TMS.
  • DARPA: SPARC-TMS selected for potential non-dilutive funding exceeding $11.5 million.
  • Financing: $22.3 million public offering completed.
  • GeNeuro: HERV-targeted clinical portfolio expanded within NRx.
  • Today's catalyst: European patent awarded for GNK-301 targeting ALS.

The GeNeuro development is particularly interesting because it adds a neurodegenerative disease opportunity to a company whose primary focus has historically been neuropsychiatric conditions.

Investor Perspective

NRx Pharmaceuticals remains a speculative biotechnology investment. Regulatory decisions, clinical outcomes, commercialization, financing requirements and development timelines all carry significant risks, and today's developments do not guarantee future approvals or commercial success.

Nevertheless, the NRXP story is becoming increasingly diversified.

The company is simultaneously approaching a potential commercial milestone with preservative-free ketamine, expanding HOPE Therapeutics, deploying increasingly sophisticated TMS technology, advancing NRX-101 through a potentially significant DARPA-supported program and now highlighting a growing GeNeuro intellectual-property portfolio focused on diseases such as ALS.

Today's European patent award for GNK-301 is therefore more than another patent announcement.

It demonstrates that the GeNeuro platform is beginning to produce tangible intellectual-property milestones while NRx's other programs continue advancing.

At the same time, HOPE Therapeutics is preparing to deploy FDA-cleared robotic TMS technology, creating a potentially powerful connection between NRx's clinical infrastructure and NRX-101 development.

With management continuing to meet investors at major healthcare conferences and multiple regulatory, clinical and commercial milestones ahead, NRx Pharmaceuticals is entering the remainder of 2026 with considerably more catalysts than it had just a few months ago.

For more information on $NRXP visit:
https://www.nrxpharma.com/ and https://compasslivemedia.com/case-study/nrx-pharmaceuticals/

Media Contact
Company Name: NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
Contact Person: Brian Korb, Managing Partner, astr partners
Email: [email protected]
Phone: (917) 653-5122
Country: United States

DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website

Contact
CorporateAds
***@gmail.com

Photos: (Click photo to enlarge)




Source: CorporateAds

Read Full Story - European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP | More news from this source

Press release distribution by PRLog
MORE NEWS
SK hynix, gov't to provide $1.5 bil. in loan guarantees to semiconductor suppliers
Oct 19, 2026
SK hynix, gov't to provide $1.5 bil. in loan guarantees to semiconductor suppliers

Korean chip giant SK hynix said Monday it will partner with the government and major banks to provide 2 trillion won ($1.5 billion) in loan guarantees to local semiconductor suppliers to strengthen the domestic chip supply chain. SK hynix and the Ministry of Trade, Industry and Resources signed an agreement to launch the program at the chipmaker's semiconductor cluster promotion center in Yongin, south of Seoul. Under the agreement, SK hynix and four major banks will contribute a combined 100 billion won to support the program, while the state-run Korea Trade Insurance Corp. (K-SURE) will provide up to 2 trillion won in loan guarantees to semiconductor materials, parts and equipment suppliers. Suppliers recommended by SK hynix will benefit from higher loan limits, interest rate cuts of up to 2.5 percentage points and a guarantee period extended from one to three years. The initiative is part of the government's broader push to strengthen export supply chains by improving access to financing for smaller companies working with major manufacturers. The government previously pledged 2.4 trill

Hyundai Rotem Q3 net down 10.3% to $133.9 mil
Oct 19, 2026
Hyundai Rotem Q3 net down 10.3% to $133.9 mil

Hyundai Rotem, the defense and railway subsidiary of Hyundai Motor Group, said Monday its third-quarter net profit fell about 10 percent from a year earlier. Net profit for the July-September period decreased 10.3 percent to 177.98 billion won ($133.9 million), the company said in a regulatory filing. Operating profit also declined 11 percent on-year to 247.1 billion won, while sales inched up 0.1 percent to 1.62 trillion won. For the first nine months of the year, cumulative sales rose 11.2 percent on-year to 4.68 trillion won, while operating profit fell 4.7 percent to 703.7 billion won. The company's order backlog stood at 29.14 trillion won at the end of September, down 1.26 trillion won from three months earlier. Separately, Hyundai Rotem said it plans to acquire Hyundai Wia's defense business for 358.4 billion won to bolster its weapons production capabilities, a move expected to help boost overseas sales of its flagship K2 tanks.

Fathers take on more, but mothers still bear heavier domestic workload
Oct 19, 2026
Fathers take on more, but mothers still bear heavier domestic workload

For a 33-year-old bank employee surnamed Jung raising a 3-year-old son in Seoul’s Yeongdeungpo District, coming home from work feels like starting a second shift. She uses a reduced working hours program for parents to leave work an hour or two early. Once her mother-in-law, who looks after the child while the couple are at work, heads home, Jung handles child care alone until her husband returns. “As soon as I get home, I feed my son dinner, bathe him and play with him. By then, my husband is home,” she said. “While he plays with our son, I finally get to shower, wash the dishes and tidy up. Then it’s time to put our son to bed.” Jung gets her first chance to sit down on the sofa after her son falls asleep, past 10 p.m. “Even though I leave work early, it feels like I work overtime every day,” she said. “My husband does quite a lot of child care, but our son tends to seek me out more, and I feel that a larger share of the housework naturally falls to me.” Government figures released Monday show that an uneven division of domestic duties persists among young working pa

Gov't, businesses team up to help retired detection dogs find new homes
Oct 19, 2026
Gov't, businesses team up to help retired detection dogs find new homes

The Ministry of Agriculture, Food and Rural Affairs last week joined Trinity Airways and Sono Pet Clubs & Resorts for a two-day pet adoption program, combining government support for retired detection dogs with private-sector assistance in event planning, accommodation and training. The Animal and Plant Quarantine Agency under the ministry provided guidance on adoption procedures and answered prospective owners’ questions. Trinity Airways, formerly T’way Air, organized the program, held Saturday and Sunday, while Sono Pet provided spaces for families and dogs to interact and rest, along with professional training support. Held at Sono Pet’s Vivaldi Park in Hongcheon, Gangwon Province, the program brought together three retired quarantine detection dogs and three prospective adoptive families selected through a screening process, according to the agency. The dogs were two English springer spaniels, aged 7 and 9, and a 9-year-old beagle. Activities included running together, treasure hunts and walks, giving participants opportunities to interact with the dogs. A trainer specializing

Finda to become 1st fintech firm to acquire savings bank
Oct 19, 2026
Finda to become 1st fintech firm to acquire savings bank

Finda, a loan comparison platform, is set to acquire a savings bank, in what would be a first for a Korean fintech company as it looks to build an artificial intelligence (AI)-native bank, industry officials said Monday. The Financial Services Commission's subcommittee approved Finda's application to acquire Daewon Savings Bank on Friday. The regulator is set to make a final decision at its regular meeting Wednesday. Finda signed a deal in June to acquire all of Daewon Savings Bank's shares for about 12 billion won ($9 million). The acquisition would allow the company to move beyond matching borrowers with lenders and offer financial services directly, including loans and deposits. Once the deal receives final approval, Finda plans to appoint a new CEO through board and shareholder meetings. The fintech firm aims to turn the lender into an AI-native bank, relying on digital services rather than a traditional network of branches. It plans to draw on AI technology and loan-comparison data it has collected since 2019 to expand its online lending business nationwide, the firm said. The compan

Global AI & Digital Summit kicks off 3-day run in Seoul
Oct 19, 2026
Global AI & Digital Summit kicks off 3-day run in Seoul

A global event aimed at exploring how artificial intelligence (AI) and digital transformation can deliver practical development gains kicked off its three-day run in Seoul on Monday, the science ministry said. The Global AI & Digital Summit, co-hosted by the ministry and the World Bank Group — a family of five institutions that makes leveraged loans to developing countries —brought together government officials from some 60 nations, as well as development partners, private sector leaders and researchers. This year marks the first time the summit was held outside of the United States, the ministry added. The event will begin with an AI and Digital Ministerial meeting, co-chaired by Science Minister Bae Kyung-hoon and Kim Sang-bu, the vice president for digital and AI at the World Bank Group, followed by policy forums and exhibitions from participating companies. Korea has been hosting the AI and digital ministerial meeting since 2005, with the most recent gathering held last year on the sidelines of the Asia Pacific Economic Co-operation (APEC) forum. Second Vice Science Minister Ryu J

Hyundai Rotem acquires Wia's defense biz as group reorganizes portfolio
Oct 19, 2026
Hyundai Rotem acquires Wia's defense biz as group reorganizes portfolio

Hyundai Rotem, a Hyundai Motor Group affiliate that manufactures the K2 battle tank, will acquire the defense business unit of fellow affiliate Hyundai Wia for 358.4 billion won ($252 million), as their parent company seeks to strengthen its competitiveness by consolidating its defense operations. According to the two companies’ regulatory filings, Hyundai Rotem will acquire Hyundai Wia's defense business, which manufactures main gun barrels for battle tanks and self-propelled howitzers. The two sides signed the contract on Monday and plans to close the deal by March 31. Hyundai Rotem’s main businesses include railway vehicles, such as trains and trams, and weapons systems for land, naval and air operations. Hyundai Wia manufactures engines, modules and gun barrels, supplying the barrels for both Hyundai Rotem’s K2 battle tanks and K9 self-propelled howitzers produced by Hanwha Aerospace. The acquisition will allow Hyundai Rotem to manufacture both complete K2 battle tanks and their main guns, reducing manufacturing costs and improving supply chain management efficiency. By bringi

Global cooperation, corporate innovation key to navigating AI uncertainty
Oct 19, 2026
Global cooperation, corporate innovation key to navigating AI uncertainty

JINJU, South Gyeongsang Province — International cooperation and corporate innovation have emerged as key priorities for navigating artificial intelligence (AI)-driven change and narrowing the digital divide, as former United Nations officials and executives from major conglomerates discussed ways to promote inclusive growth on Monday. The 2026 Jinju International Forum on Entrepreneurship, held on Monday and Tuesday, brought together international organization officials and business executives to discuss how entrepreneurship can help businesses navigate geopolitical tensions, supply chain realignments and rapid advances in AI. The first session, moderated by Oh Joon, the 71st president of the U.N. Economic and Social Council (ECOSOC), focused on the role of international organizations in promoting inclusive development as digital technologies reshape economies. Nestor Osorio, the council's 69th president, called for broader digital access and support for small-scale agricultural producers, arguing that technological progress must benefit communities beyond major cities and large corp

2.76 mil. pieces of customers' info at Hollys leaked in cyberattack
Oct 19, 2026
2.76 mil. pieces of customers' info at Hollys leaked in cyberattack

Customer information held by local coffee chain Hollys has reportedly been leaked via hacking of its memberships program, the franchise said Monday, the latest in a string of cyberattacks targeting local companies. A total of 2.76 million pieces of personal information, including the customers' dates of birth, phone numbers, addresses and emails, was stolen by the hackers sometime between Sept. 3 and Oct. 7, when the company detected unauthorized access to its system, according to a notice posted on the company's website. "We understand that the leaked data consists of temporary data files provided for a past membership service overhaul, not the data from the currently active customer database," the notice read, adding the company is still investigating the exact scope of the incident. "We sincerely apologize for causing customer concern from this incident. We will make our utmost efforts to protect customer data and minimize damage from the breach," it added. The cybersecurity violation at Hollys follows back-to-back leaks of customer data at local financial firms early this month. Arou

Hyundai Glovis plans Philadelphia port expansion, vehicle terminal operations
Oct 19, 2026
Hyundai Glovis plans Philadelphia port expansion, vehicle terminal operations

Hyundai Glovis plans to extend its dedicated site agreement at the Port of Philadelphia through 2056 and enter the vehicle terminal operations business, expanding its role at the key logistics hub on the east coast of the United States. The Korean company said Monday that it had signed a memorandum of understanding with the Philadelphia Regional Port Authority, known as PhilaPort, and a local developer to cooperate on port expansion and vehicle terminal operations. The agreement includes securing an additional vehicle logistics space and extending the existing site. Hyundai Glovis plans to participate in the vehicle segment of PhilaPort’s broader expansion, securing a dedicated berth for car carriers and adding terminal operations to its existing transport and storage services. Pennsylvania Gov. Josh Shapiro and state and port officials attended the expansion announcement, where Hyundai Glovis was introduced as a major private-sector partner. The event outlined plans for container and vehicle terminals and public-private cooperation. Hyundai Glovis has handled vehicle import and export

SK hynix's potential Solidigm IPO conflicts with shareholder protection rules: watchdog chief
Oct 19, 2026
SK hynix's potential Solidigm IPO conflicts with shareholder protection rules: watchdog chief

Korean regulators believe SK hynix’s potential listing of its NAND flash memory subsidiary Solidigm in the United States would run counter to rules governing listings of both parent companies and their subsidiaries, Financial Supervisory Service (FSS) Gov. Lee Chan-jin said Monday. “We are continuing to monitor the Solidigm issue. Both the Financial Services Commission (FSC) and the FSS consider it to conflict with those rules,” Lee said. He was responding to Rep. Park Sung-hoon of the main opposition People Power Party during a National Assembly audit. Park accused SK hynix of leaving domestic shareholders uninformed while explaining to the U.S. Securities and Exchange Commission that listing a subsidiary could adversely affect the parent firm’s share price. Solidigm was established in the United States through SK hynix’s $9 billion acquisition of Intel’s NAND flash memory business. SK hynix has maintained that no decision has been finalized on an initial public offering (IPO), saying Solidigm is exploring ways to strengthen its competitiveness. Still, expectations of a stock

Jinju forum returns for 4th straight year
Oct 19, 2026
Jinju forum returns for 4th straight year

JINJU, South Gyeongsang Province — The Jinju International Forum on Entrepreneurship opened Monday for its fourth consecutive year, bringing together business leaders, scholars, policymakers and international representatives to explore how entrepreneurship can address global uncertainty and rapid digital transformation. Held under the theme “An Era of Global Uncertainty and Digital Transformation: What Is the Role of Entrepreneurship?,” the 2026 forum focuses on how entrepreneurship can drive innovation, promote sustainable prosperity and address challenges such as technological disparities, demographic changes and the climate crisis. In his welcoming remarks, Jinju Mayor Jo Kyoo-il highlighted the city's entrepreneurial heritage, saying its emphasis on respect for people, community responsibility and innovation offered valuable lessons for navigating today's technological and economic changes. Jinju is deeply connected to the entrepreneurial roots of major Korean business groups, including LG, GS, Samsung and Hyosung, whose founders helped drive Korea's economic transformation, J

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.